Objectives: Propetamphos (PPT) is an organophosphate pesticide (OP) widely used to control insects in public health settings and methylethylphosphoramidothioate (MEPT) is a urinary exposure marker of PPT. The objectives of this study were to develop a biomonitoring method for urinary MEPT using gas chromatography-mass spectrometry (GC-MS) and to measure urinary MEPT concentrations in occupational and non-occupational human populations. Methods: Analytes derivatized with pentafluorobenzyl bromide were analyzed by GC-MS and dibutyl phosphate was used as an internal standard. The validated method was applied to urine samples collected from occupational PPT sprayers (n = 15), non-PPT sprayers (n = 15) who did not spray PPT but sprayed other OPs, and control subjects (n = 80) living in Aichi, Japan. Results: Calibration curves were obtained using standard-spiked pooled urine samples, and the coefficients of determination were ≥ 0.98. The limit of detection (LOD) was 10 μg/L. The within-run precision and between-run precision ranged from 17.5% to 19.4% and 10.4% to 18.1%, respectively. The detection rates of urinary MEPT in the PPT sprayers, non-PPT sprayers, and control subjects were 26.7%, 6.7%, and 2.5%, respectively. The concentration ranges for creatinine-unadjusted MEPT were < LOD-22.3, < LOD-21.9 and < LOD-13.8 μg/L, and creatinine-adjusted MEPT were < LOD-12.1, < LOD-12.7 and < LOD-7.9 μg/g creatinine, for the respective groups (PPT sprayers, non-PPT sprayers and controls). Conclusions: This study established a biomonitoring method that can measure urinary MEPT in spraying and non-spraying workers with exposure levels ≥ 10 μg/L.